EC Neurology

Research Article Volume 15 Issue 4 - 2023

MRI Features of Brain and Spine in Patients Series with Mucopolysaccharidosis

Khadija Laasri1*, Abderrazzak Ajertil2, Manal Jidal1, Siham El Haddad1, Nazik Allali1, Abdeljalil El Quassar2 and Latifa Chat1

1Pediatric Radiology Department, Children’s Hospital, Ibn Sina Hospital, Mohamed V University, Rabat, Morocco
2Radiology Department, Cheikh Zaid’s Hospital, International University Hospital, Rabat, Morocco

*Corresponding Author: Khadija Laasri, Pediatric Radiology Department, Children’s Hospital, Ibn Sina Hospital, Mohamed V University, Rabat, Morocco.
Received: March 09, 2023; Published: March 15, 2023

Background: Mucopolysaccharidosis represent a group of rare hereditary disorders characterized by multisystem involvement due to intralysosomal glycosaminoglycans accumulation. Central and peripheral nervous systems are both affected by almost all types of disease among various tissue. Therefore, brain and spinal MRI are valuable tools for assessing neurologic involvement, and there is evidence that they may be accurate indicators of disease severity and the efficacy of current treatment options in patients with MPS.

Aim: To describe the magnetic resonance imaging findings of the brain and spine in patients with mucopolysaccharidosis and correlate them with the type of MPS and clinical severity, and finally to compare these findings with those previously reported.

Materials and Methods: Retrospective evaluation was conducted of brain and spine MRI of 12 patients diagnosed with MPS from 2021 to this day, of these patients, 8 had type I (6 with Hurler syndrome and 2 with Hurler-Scheie syndrome), 2 had type II or Hunter syndrome (1 with the severe form and 1 with the mild form), 1 had type III or Sanfilippo syndrome and 1 had type VI or Maroteaux-Lamy syndrome.

Results: We enrolled 12 patients affected by MSP (07 females and 06 males, age range 5 - 14 years at the time of MRI). We observed a wide spectrum of MRI anomalies. In brain MRI: perivascular space enlargements (n = 08/12; 20%), white matter signal alterations (n = 06/12; 15%), ventriculomegaly/hydrocephalus (n = 05/12; 12%), Cortical and subcortical cerebral atrophy (n = 04/12; 10%), Posterior fossa abnormalities (n = 04/12; 10%), arachnoid cyst (n = 04/12; 10%), closed meningo-encephalocele (n = 02/12; 5%), bilateral optic nerve sheaths enlargement (n = 02/12; 5%), craniosynostosis (scaphocephaly: n = 04/12; 10%), morphological abnormality of sella turcica (n = 01/12; 3%). In spine MRI: periodontoid soft-tissue thickening (n = 07/12; 20%), spinal canal stenosis (n = 07/12; 20%), cord compression (n = 04/12; 11%), myelopathy (n = 02/12; 6%), syringomyelia (n = 02/12; 6%), Odontoid hypoplasia (n = 03/12; 8%), morphological abnormality of vertebral bodies (n = 07/12; 20%), kyphosis (n = 02/12; 6%), scoliosis (n = 01/12; 3%).

Conclusion: The spectrum of brain and spinal MRI abnormalities in MPS is extremely broad (Perivascular space enlargements, white matter signal alterations, ventriculomegaly/hydrocephalus, cerebral atrophy, periodontoid soft-tissue thickening, spinal canal stenosis; with/or without cord compression or myelopathy, vertebral/skull abnormalities). Therefore, given these abnormalities, we should be aware of this possible diagnosis, especially when typical signs and symptoms are present. However, we did not find a correlation between these findings and either any specific type of MPS or clinical severity.

Keywords: Mucopolysaccharidosis; Glycosaminoglycans; Magnetic Resonance Imaging; Brain; Spine

  1. Zafeiriou DI., et al. "Brain and spinal MR imaging findings in mucopolysaccharidoses: a review”. American Journal of Neuroradiology 1 (2013): 5-13.
  2. Lins CF., et al. "MRI findings of the cervical spine in patients with mucopolysaccharidosis type VI: relationship with neurological physical examination”. Clinical Radiology 6 (2020): 441-447.
  3. Reichert R., et al. "Neuroimaging findings in patients with mucopolysaccharidosis: what you really need to know”. Radiographics5 (2016): 1448-1462.
  4. Damar Ç., et al. "Posterior fossa horns; a new calvarial finding of mucopolysaccharidoses with well-known cranial MRI features”. Turkish Journal of Medical Sciences 4 (2020): 1048-1061.
  5. GeroM LC., et al. "Neuroimaging findings in patient series with mucopolysaccharidosis”. Neurología 7 (2012): 407-413.
  6. Vedolin L., et al. "Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings”. Neurology 9 (2007): 917-924.
  7. Cheon JE, et al. "Leukodystrophy in children: a pictorial review of MR imaging features”. Radiographics 3 (2002): 461-476.
  8. Kirkpatrick K., et al. "Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management”. Pediatric Anesthesia 8 (2012): 745-751.
  9. Matheus MG., et al. "Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation”. Neuroradiology 46 (2004): 666-672.
  10. Machnikowska-Sokołowska M., et al. "Mucopolysaccharidosis Type 1 among Children-Neuroradiological Perspective Based on Single Centre Experience and Literature Review”. Metabolites2 (2023): 209.
  11. Gabrielli O., et al. "Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses”. American Journal of Medical Genetics Part A 3 (2004): 224-231.
  12. Seto T., et al. "Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation”. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 1 (2001): 79-92.
  13. Manara R., et al. "Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy”. Journal of Inherited Metabolic Disease: Official Journal of the Society for the Study of Inborn Errors of Metabolism 3 (2011): 763-780.
  14. Ramos-Villegas Y., et al. “Neuroradiological Characteristics in Patients with Mucopolysaccharidosis Type II: A Systematic Review”. Journal of Medical Academics 1-2 (2022): 13.
  15. Matsubara Y., et al. "Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis”. Pediatric Radiology 47 (2017): 1659-1669.
  16. Alqahtani E., et al. "Mucopolysaccharidoses type I and II: new neuroimaging findings in the cerebellum”. European Journal of Paediatric Neurology 2 (2014): 211-217.
  17. Reichert R., et al. "Magnetic resonance imaging findings of the posterior fossa in 47 patients with mucopolysaccharidoses: A cross‐sectional analysis”. JIMD Reports 1 (2021): 32-41.
  18. Rasalkar, D., et al. "Pictorial review of mucopolysaccharidosis with emphasis on MRI features of brain and spine”. The British Journal of Radiology 1001 (2011): 469-477.
  19. Palmucci S., et al. "Imaging findings of mucopolysaccharidoses: a pictorial review”. Insights into Imaging 4 (2013): 443-459.
  20. Friedmann I., et al. "Histopathological studies of the temporal bones in Hurler's disease [mucopolysaccharidosis (MPS) IH]”. The Journal of Laryngology and Otology 1 (1985): 29-42.
  21. Petitti N., et al. "Mucopolysaccharidosis III (Sanfilippo syndrome) type B: cranial imaging in two cases”. Journal of Computer Assisted Tomography 6 (1997): 897-899.
  22. Nicolas-Jilwan M., et al. "Mucopolysaccharidoses: overview of neuroimaging manifestations”. Pediatric Radiology 48 (2018): 1503-1520.
  23. Ashworth Jane L., et al. "The ocular features of the mucopolysaccharidoses”. Eye 5 (2006): 553-563.
  24. González A., et al. "Encephalocele in a patient with Hurler syndrome: description and therapeutic alternatives review”. Acta de Otorrinolaringología and Cirugía de Cabeza y Cuello 1 (2022): 73-76.
  25. Manara R., et al. "Closed Meningo (encephalo) cele: a new feature in Hunter syndrome”. American Journal of Neuroradiology 33.5 (2012): 873-877.
  26. Nakaoka S., et al. "Mucolipidosis Ⅱ and III with neurological symptoms due to spinal cord compression”. Brain and Development 8 (2021): 867-872.
  27. SolankiG A., et al. "Cervical cord compression in mucopolysaccharidosis VI (MPS VI): Findings from the MPS VI Clinical Surveillance Program (CSP)”. Molecular Genetics and Metabolism 4 (2016): 310-318.
  28. Almeida JV., et al. "Spinal cord occupation ratio (SCOR) and its application in the diagnosis of cervical spinal cord compression in Mucopolysaccharidoses”. Journal of Inborn Errors of Metabolism and Screening 10 (2022).
  29. Crostelli M., et al. "Spine challenges in mucopolysaccharidosis”. International Orthopaedics 43 (2019): 159-167.
  30. Wilson S., et al. "Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities”. The American Journal of Pathology 5 (2009): 2053-2062.
  31. Kulkarni MV., et al. "Magnetic resonance imaging in the diagnosis of the cranio-cervical manifestations of the mucopolysaccharidoses”. Magnetic Resonance Imaging 5 (1987): 317-323.
  32. Parsons VJ., et al. "Magnetic resonance imaging of the brain, neck and cervical spine in mild Hunter's syndrome (mucopolysaccharidoses type II)”. Clinical Radiology 10 (1996): 719-723.
  33. Hite SH., et al. "Syringomyelia in mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): imaging findings following bone marrow transplantation”. Pediatric Radiology 27 (1997): 736-738.
  34. Rezayi A., et al. "An uncommon presentation of mucopolysaccharidosis type IIIb”. Iranian Journal of Child Neurology 3 (2019): 105.

Khadija Laasri., et al. “MRI Features of Brain and Spine in Patients Series with Mucopolysaccharidosis”. EC Neurology  15.4 (2023): 53-69.